Advanced cell sorting technology for medical research
Official title: The BD FACSDiscover S8 Cell Sorter for Flow Cytometric Sorting
Funded at Pennsylvania State Univ Hershey Med Ctr · NIH-11100882 · Data updated 2026-11-12
This study is all about getting a new, high-tech machine that helps scientists at Penn State College of Medicine sort out different types of cells more quickly and accurately, which is really important for their research on diseases like cancer and heart problems.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State Univ Hershey Med Ctr NIH-funded |
| Lab location | 1 site (Hershey, United States) |
| Project start | May 15, 2025 |
| Project end | May 14, 2026 |
| Funding year | 2025 |
| Award (this year) | $631,365 |
| NIH project number | 1S10OD038168-01 |
| Project ID | NIH-11100882 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals involved in NIH-funded biomedical research projects that require advanced cell sorting techniques.
✕Less likely to help
Patients not engaged in research or those whose conditions do not require cell sorting technology may not benefit from this research.
What this research studies
This research focuses on acquiring a state-of-the-art cell sorter, the BD FACSDiscover S8, to enhance the capabilities of the Flow Cytometry Core Facility at Penn State College of Medicine. The new technology will allow researchers to isolate specific cell populations from complex mixtures using advanced fluorescent biomarkers, which are excited by lasers to produce signals that identify different cell types. This process is crucial for various NIH-funded projects, enabling faster and more accurate cell sorting for experiments related to diseases like cancer and cardiovascular disorders.
Why it matters
Potential benefit: If successful, this research could significantly improve the efficiency and accuracy of cell sorting for various medical studies, leading to better understanding and treatment of diseases.
How similar studies have gone: Previous research has demonstrated the effectiveness of advanced flow cytometry techniques in improving cell sorting outcomes, indicating a strong potential for success with this new technology.
Where this research is happening
-
Pennsylvania State Univ Hershey Med Ctr
Hershey, United States Active
Researchers
- Principal investigator: Schell, Todd D — Pennsylvania State Univ Hershey Med Ctr
- Study coordinator: Schell, Todd D
Related research
Other NIH-funded projects on the same topics.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Understanding the STIM/Orai Calcium Signaling Pathway in Cancer
Researchers are studying how STIM and Orai proteins control calcium signals inside cells and how this affects cancer-related growth and remodeling, with hopes to find ways to influence these signals for better treatments.
-
Understanding how some Amish communities maintain high birth rates in modern times
A project will build a large, time-sensitive dataset to understand why Amish families keep having many children, even as broader society has much lower birth rates.
-
Scoliosis and neurosurgical factors in myelomeningocele: a clinic registry study
This project uses registry data from Penn State’s Spina Bifida Clinic to understand how brain and spine-related issues influence when and why scoliosis surgery is needed in people with myelomeningocele.
-
Understanding how damaged stomach cells revert to a repair state to prevent cancer
Researchers are studying how certain stomach cells re-enter the cell cycle to aid tissue repair, and how this process might lead to metaplasia or cancer if it goes wrong.
-
Aging, cell aging, and how MCPyV causes Merkel cell carcinoma
Aging and aging-related changes in skin cells may help a common virus (MCPyV) persist and potentially lead to a rare skin cancer in people with weaker immune systems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.